Lumito AB (NGM:LUMITO) Beginning Cash Position: kr8.99 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:LUMITO Lumito AB NGM:LUMITO
16 GF Score
Price kr1.01
! 2 Warning Signs
View Full Analysis

What is Lumito AB Beginning Cash Position?

Lumito AB NGM:LUMITO -3.63% 16 Beginning Cash Position is kr8.99 Mil as of Jun. 2026. GuruFocus rates NGM:LUMITO with a GF Score™ of 16/100. The stock has 2 warning signs investors should review.

Lumito AB's Beginning Cash Position for the quarter that ended in Jun. 2026 was kr8.99 Mil.

Lumito AB's quarterly Beginning Cash Position declined from Dec. 2025 (kr24.54 Mil) to Mar. 2026 (kr15.78 Mil) and declined from Mar. 2026 (kr15.78 Mil) to Jun. 2026 (kr8.99 Mil).

Lumito AB's annual Beginning Cash Position declined from Dec. 2023 (kr52.72 Mil) to Dec. 2024 (kr22.45 Mil) and declined from Dec. 2024 (kr22.45 Mil) to Dec. 2025 (kr21.59 Mil).

Lumito AB Beginning Cash Position Related Terms

Lumito AB Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Lumito AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumito AB Beginning Cash Position Chart

Lumito AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only 39.98 35.44 52.72 22.45 21.59

Lumito AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.71 7.13 24.54 15.78 8.99
NGM:LUMITO
16GF Score
Lumito AB NGM:LUMITO
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lumito AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of kr8.99 Mil mean?
Lumito AB (NGM:LUMITO) has a Beginning Cash Position of kr8.99 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Lumito AB and its competitors.
Is Lumito AB's Beginning Cash Position too high?
Lumito AB's current Beginning Cash Position is kr8.99 Mil. Overall, Lumito AB has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Lumito AB's Beginning Cash Position compare to TMO and DHR?
Lumito AB's Beginning Cash Position of kr8.99 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Lumito AB and its competitors. Lumito AB's current Beginning Cash Position is kr8.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumito AB stock overvalued right now?
Lumito AB (NGM:LUMITO) has a current Beginning Cash Position of kr8.99 Mil. The current Beginning Cash Position is kr8.99 Mil. Lumito AB's overall GF Score™ is 16/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Lumito AB (NGM:LUMITO), the current Beginning Cash Position is kr8.99 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lumito AB Business Description

Address Scheelevagen 19, Lund, SWE, 223 63
Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed the next-generation tissue analysis system, based on upconverting nanoparticles (UCNPs). Lumito SCIZYS is a cutting-edge, high-sensitivity system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples. The company holds a broad patent portfolio of three patent families. Lumito's solution enables quantitative and objective assessment of tissue samples, addressing a multitude of challenges in drug development and academic research.
16GF Score

Get the complete analysis for NGM:LUMITO

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.01
Price